PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

PCI Clinical Services Announces Site Expansion to Support Growth and Flexibility

Rockford, IL Center of Excellence to add 30,000 additional sq ft of space. Philadelphia, USA – November 14, 2018 PCI Pharma Services (PCI), a full-service provi...
Continue Reading →
News

‘Record year for pharma packaging and drug delivery innovation’ says Pharmapack

Event sees more innovation centralising at the Paris hub with entries for the awards and Start-up Hub opening  In an all-time record year for FDA approvals (...
Continue Reading →
News

Peli BioThermal Announces Wilpak Global Partnership

Thermal covers offer another option for protecting temperature-sensitive pharmaceuticals Peli BioThermal, the global name in temperature controlled packaging, a...
Continue Reading →
News

C-CAMP, AUM Biosciences partner to develop small-molecules as anti-cancer drugs

This partnership recognizes AUM Biosciences (AUM), a Singapore-based biotechnology company, as an international incubatee of C-CAMP in the pursuit of developing nove...
Continue Reading →
News

Roche gains speedy review for Tecentriq in first-line breast cancer

Roche could soon see Tecentriq become part of the first immunotherapy combination approved to treat triple-negative breast cancer, after gaining a priority review fr...
Continue Reading →
News

Obesity both feeds tumors and helps immunotherapy kill cancer

A groundbreaking new study by UC Davis researchers has uncovered why obesity both fuels cancer growth and allows blockbuster new immunotherapies to work better again...
Continue Reading →
News

AstraZeneca to divest US Synagis rights to Sobi

AstraZeneca has agreed to sell US rights to Synagis (palivizumab) used for the prevention of serious lower respiratory tract infection (LRTI) caused by respiratory s...
Continue Reading →
News

Machine learning for pharma marketers: The time is now to budget, experiment and adjust, expert says

When does CMI/Compas executive Paul Kallukaran think pharma companies should start looking at using machine learning in their marketing strategies? "Yesterday,"...
Continue Reading →
News

Social media scheme boosts breast cancer screening uptake

An NHS project using social media has driven a 13% increase in first time attendances for breast screening in Stoke-on-Trent over four years. Under the local in...
Continue Reading →
News

Five new technology centres to drive earlier diagnoses

Business Secretary Greg Clark has announced five new centres of excellence for digital pathology and imaging in England, which will use advances in medical arti...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026